Epigenic Therapeutics Announces $32 Million In Series A Funding To Bring Breakthrough Epigenome Medicine To Clinical Development
Amount Raised
$32 Million
Round Type
Series A
ShanghaiBiotechnologyHealth CareresearchInvestors
Description
Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy utilizing epigenome regulation to treat prevalent diseases, today announced that it has raised $32 million in Series A round of financing co-led by Qiming Venture Partners and OrbiMed, with participation from existing investor Morningside Venture Capital. This round of financing will support the preclinical development and early clinical validation of two leading programs, discovery of future pipelines, expansion of the leadership team, and continued investments in the company's core technology platforms.
Quick answer
Epigenic Therapeutics raised $32 Million in a Series A round, dated August 30, 2023. Investors: Morningside Venture Capital, Orbi Med and Qiming Venture Partners. Epigenic Therapeutics is based in Shanghai, Shanghai, China.
- How much did Epigenic Therapeutics raise?
- Epigenic Therapeutics raised $32 Million in a Series A round on August 30, 2023.
- Who invested in Epigenic Therapeutics?
- Morningside Venture Capital, Orbi Med and Qiming Venture Partners are named as investors in this round.
- What does Epigenic Therapeutics do?
- Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases.
- Where is Epigenic Therapeutics based and how big is it?
- Epigenic Therapeutics is based in Shanghai, Shanghai, China. Fundz records about 13 employees.
- Who are the decision-makers at Epigenic Therapeutics?
- Fundz holds 2 contacts at Epigenic Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in research and Biotechnology around the same time
Companies in the same sectors as Epigenic Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- SeaBeLife raised $1.3M (Seed) on September 27, 2023.
- Aptose Biosciences raised $3M (Seed) on September 6, 2023.
- QuantHealth raised $15M (Series A) on August 31, 2023.
- Bionano Genomics raised $35M on October 13, 2023.
- Greenbrook TMS raised $1.5M (Seed) on October 13, 2023.
- RDS raised an undisclosed amount (Seed) on October 12, 2023.
Who to call at Epigenic Therapeutics, and when
A new round usually means Epigenic Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Epigenic Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Epigenic Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Epigenic Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Epigenic Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEpigenic Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.